The Melanoma Research Alliance Names Dr. Marc Hurlbert as Chief Executive Officer

11 May 2022 In Allies & Partnerships, News

The Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research, today announced that its Board of Directors appointed Marc Hurlbert, PhD, as its new Chief Executive Officer.

Read More

Dr. Gary Deng & The Wellness Principles

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 9 May 2022 In Allies & Partnerships, Prevention, Treatment

Gary Deng, MD, PhD – an integrative medicine specialist at Memorial Sloan Kettering Cancer Center – knows this firsthand. And now, for the first time, Dr. Deng is sharing his unique and highly respected wellness approach with everyone through his upcoming book, The Wellness Principles – Cooking for a Healthy Life.

Read More

Why I Step - Lynn Merrill Iverson

By Renee Orcione, MRA Digital Engagement & Communications Manager | 25 April 2022 In Allies & Partnerships, Events, Melanoma Stories

In 2021, as part of MRA’s inaugural Step Up for Melanoma challenge, Lynn joined hundreds of supportive and passionate individuals across the country to share Bert’s story, keep his memory alive, raise awareness, and complete 310,000 steps during Melanoma Awareness Month.

Read More

A Message from the Melanoma Research Alliance

21 April 2022 In News

Michael Kaplan, MRA’s President & CEO, will retire on April 30, 2022. Kaplan, who has led the Melanoma Research Alliance since 2016, will be succeeded by Dr. Marc Hurlbert.

Read More

What You Control: Your Microbiome, Diet, Stress, & Melanoma

14 April 2022 In Science

Every day, we hear from patients who want to know what, if anything, they can do to have the best health outcomes possible. For people facing melanoma, it’s common to feel overwhelmed and out of control with everything that a melanoma diagnosis and treatment entail. Yet, how one faces those challenges, can make a big difference. MRA-funded investigator Lorenzo Cohen, PhD is working hard to help patients understand the pivotal role of the microbiome, diet, stress — and their melanoma — on treatment outcomes.

Read More

Unlocking the Potential of Localized Treatments By Better Understanding Treatment Response

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 23 March 2022 In News, Science, Treatment

It’s easy to think of melanoma – or any cancer – in black and white terms. You have it or you don’t, it responds or it’s resistant to treatment, or it grows or it shrinks. However, like most things, the reality is far more complex.

Read More

MRA Applauds Approval of Relatlimab + Nivolumab for the Treatment of Advanced Melanoma

18 March 2022 In News, Science, Treatment

The Melanoma Research Alliance (MRA) welcomed the news today that the U.S. Food & Drug Administration (FDA) has approved Opdualag™, Bristol-Myers Squibb’s new combination immunotherapy for the treatment of advanced melanoma.

Read More

Recordings from MRA's 2022 Patient Forum

16 March 2022 In Allies & Partnerships, Events, Melanoma Stories, News, Policy, Prevention, Science, Treatment

MRA’s Melanoma Exchange Patient Forum, held in-person in Washington DC and virtually on March 9, 2022, brought together hundreds of melanoma patients, survivors, advocates, and their loved ones to provide lay-friendly, state-of-the-science education, promote collaboration, and provided networking opportunities across the melanoma community.

Read More

Testing AI in the Melanoma: From Promise to Action

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 8 March 2022 In Prevention, Science

If you browse through your phone’s app store, you’ll find dozens of apps promising to help determine if a mole you’ve been staring at is cancerous or not based on the power of AI. While a great goal, none of these apps have earned approval from the Food and Drug Administration (FDA). However, to do so, apps — and the algorithms that they rely on — will need to be rigorously tested in the real world and across diverse populations. This is exactly where Dr. Novoa’s research is aimed.

Read More

Melanoma Free & Living Scan-to-Scan

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 4 March 2022 In Melanoma Stories

In 2007, while staining her deck at home, Debra Likes – who goes by Debbie – decided she’d had enough and would finally see her primary care doctor. She had been ignoring a mole on her left calf for more than a year as she watched it slowly transform from a round...

Read More